156 related articles for article (PubMed ID: 36093650)
21. Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis.
Li ML; Luo HY; Quan ZW; Huang LT; Wang JH
Int J Biol Markers; 2023 Mar; 38(1):3-14. PubMed ID: 36604990
[TBL] [Abstract][Full Text] [Related]
22. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
23. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
24. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
[TBL] [Abstract][Full Text] [Related]
25. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors.
Zong C; Zhang Z; Gao L; He J; Wang Y; Li Q; Liu X; Yang J; Chen D; Huang R; Zheng G; Jin X; Wei W; Jia R; Shen J
Cell Death Dis; 2023 Jun; 14(6):348. PubMed ID: 37270643
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Udquim KI; Zettelmeyer C; Banday AR; Lin SH; Prokunina-Olsson L
Carcinogenesis; 2020 Aug; 41(8):1030-1037. PubMed ID: 31930332
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of the Naples Prognostic Score in Patients with Gastrointestinal Cancers: A Meta-Analysis.
Chen F; Xie C; Ren K; Xu X
Nutr Cancer; 2023; 75(7):1520-1530. PubMed ID: 37177915
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
[TBL] [Abstract][Full Text] [Related]
31. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract][Full Text] [Related]
32. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
Jiang H; Li H
BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
[TBL] [Abstract][Full Text] [Related]
33. Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.
Wu J; Li N; Zhu L; Zhen D; Li M; Chen H; Ye M; Wei Y; Shao G
BMC Bioinformatics; 2022 Aug; 23(1):312. PubMed ID: 35918642
[TBL] [Abstract][Full Text] [Related]
34. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of E2F1 gene expression in human cancer: a meta-analysis.
Li J; Bi W; Lu F; Pan B; Xiong M; Nasifu L; Nie Z; He B
BMC Cancer; 2023 Jun; 23(1):509. PubMed ID: 37277745
[TBL] [Abstract][Full Text] [Related]
36. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
37. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
[TBL] [Abstract][Full Text] [Related]
38. The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis.
Wang F; Zhang L; Xu H; Li R; Xu L; Qin Z; Zhong B
J Cancer; 2019; 10(1):277-286. PubMed ID: 30662548
[No Abstract] [Full Text] [Related]
39. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
40. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
Liu H; Dai Q; Li Y; Tang Z; She T
Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
